BEARD ET AL.: 'Synthesis and biological activity of retinoic acid receptor-alpha specific amides' BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. vol. 12, 03 November 2002, pages 3145 - 3148, XP008010813 (B1)

WO-A2-2008/091620 (B1)

CHEE ET AL.: 'ATRA and the specific RARalpha agonist, NRX195183, have opposing effects on the clonogenicity of pre-leukemic murine AML1-ETO bone marrow cells' LEUKEMIA. vol. 27, 11 December 2012, pages 1369 - 1380, XP055386354 (B1)

HASHIMOTO Y ET AL: "CORRELATION OF DIFFERENTIATION-INDUCING ACTIVITY OF RETINOIDS ON HUMAN LEUKEMIA CELL LINES HL-60 AND NB4", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOL, SPRINGER INTERNATIONAL, BERLIN, DE, vol. 121, no. 11, 1 January 1995 (1995-01-01), pages 696-698, XP009002752, ISSN: 0171-5216, DOI: 10.1007/BF01218530 (B1)

JAE PARK ET AL: "Emerging new approaches for the treatment of acute promyelocytic leukemia", THERAPEUTIC ADVANCES IN HEMATOLOGY, vol. 2, no. 5, 1 October 2011 (2011-10-01) , pages 335-352, XP055606827, GB ISSN: 2040-6207, DOI: 10.1177/2040620711410773 (B1)

M. YING ET AL: "Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All-Trans-Retinoic Acid-Induced Differentiation by Modifying the RAR /STAT1 Axis", MOLECULAR CANCER THERAPEUTICS, vol. 12, no. 2, 1 February 2013 (2013-02-01), pages 195-206, XP055606848, US ISSN: 1535-7163, DOI: 10.1158/1535-7163.MCT-12-0433 (B1)

MARIKAR ET AL.: 'Retinoic Acid Receptors Regulate Expression of Retinoic Acid 4-Hydroxylaso that Specifically Inactivates All-Trans Retinoic Acid in Human Keratinocyte HaCaT Cells' JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 111, September 1998, pages 434 - 439, XP055386358 (B1)

OIKAWA ET AL.: 'Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti- angiogenic activity in vivo' EUROPEAN JOURNAL OF PHARMACOLOGY vol. 249, 02 November 1993, pages 113 - 116, XP023769723 (B1)

ORITA ET AL.: 'Modifying Effects of 1'-Acetoxychavicol Acetate (ACA) and the Novel Synthetic Retinoids Re-80, Am-580 and Am-55P in a Two-Stage Carcinogenesis Model in Female Rats' TOXICOLOGIC PATHOLOGY. vol. 32, March 2004, pages 250 - 257, XP055386373 (B1)

SALVADOR ALONSO ET AL: "Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymes", ONCOTARGET, vol. 6, no. 17, 20 June 2015 (2015-06-20), XP055607121, DOI: 10.18632/oncotarget.3614 (B1)

SUGANUMA MASAMI ET AL: "Highlights of the Twelfth Japan-Korea Joint Symposium on Cancer and Ageing Research", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, SPRINGER INTERNATIONAL, BERLIN, DE, vol. 141, no. 11, 29 March 2015 (2015-03-29), pages 1953-1961, XP035547187, ISSN: 0171-5216, DOI: 10.1007/S00432-015-1959-5 [retrieved on 2015-03-29] (B1)

Salvador Alonso ET AL: "Bone Marrow Niche - Multiple Myeloma Cross-Talk Generates Bortezomib Resistance - 57th Annual Meeting&Exposition", Blood Journal, 7 December 2015 (2015-12-07), XP055607123, Retrieved from the Internet: URL:http://www.bloodjournal.org/content/12 6/23/914?sso-checked=true [retrieved on 2019-07-18] (B1)

T SANDA ET AL: "Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis", LEUKEMIA, vol. 19, no. 6, 1 June 2005 (2005-06-01), pages 901-909, XP055606824, London ISSN: 0887-6924, DOI: 10.1038/sj.leu.2403754 (B1)

THATCHER ET AL.: 'The role of CYP26 enzymes in retinoic acid clearance' 01 August 2010, pages 1 - 21, XP008169838 (B1)

US-B1- 6 534 544 (B1)

US-B2- 6 387 950 (B1)

BINGZONG LI ET AL: "The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 290, no. 50, 19 October 2015 (2015-10-19), pages 29854-29868, XP055606853, US ISSN: 0021-9258, DOI: 10.1074/jbc.M115.664953 (B1)